What is it about?
A coincise, non biased crtiticism of the potential impact of immunotherapy for Mesothelioma
Featured Image
Why is it important?
An independent insight into reality of immunitherapy
Perspectives
To switch toward the role of micro-environment and metabolic reprogramming to reinforce immune response
Prof Luciano Mutti
Temple University
Read the Original
This page is a summary of: Anti-CTLA-4 therapy for malignant mesothelioma, Immunotherapy, March 2017, Future Medicine,
DOI: 10.2217/imt-2016-0123.
You can read the full text:
Contributors
The following have contributed to this page
